Amneal Pharmaceuticals, Inc. is a U.S.-domiciled publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey. Amneal Pharmaceuticals was founded in 2002 by brothers Chirag and Chintu Patel. The company manufactured its first Rx product in 2005 and received its first ANDA approval in 2006.

Amneal Receives Approval for Difluprednate Ophthalmic Emulsion

Amneal to Virtually Participate at Upcoming Investor Conferences

15 Best Single-Digit Stocks to Buy Now

Amneal Pharmaceuticals, inc (AMRX) Q3 2021 Earnings Call Transcript

Amneal Pharmaceuticals (AMRX) Tops Q3 Earnings Estimates

Amneal Reports Third Quarter 2021 Financial Results

Amneal Releases Inaugural Corporate Responsibility Report Highlighting Our Impact as a Socially Responsible Company

Amneal Pharmaceuticals (AMRX) to Report Q3 Results: Wall Street Expects Earnings Growth

Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA

Why the Earnings Surprise Streak Could Continue for Amneal (AMRX)

Based On Its ROE, Is Amneal Pharmaceuticals, Inc. (NYSE:AMRX) A High Quality Stock?

Amneal to Report Third Quarter 2021 Results on November 3, 2021

Amneal to Virtually Participate at Morgan Stanley 19th Annual Global Healthcare Conference

Amneal (AMRX) Parkinson's Candidate Successful in Pivotal Study

Amneal's Parkinson's Candidate Shows Efficacy In Pivotal Trial

Amneal Announces Positive Topline Results from Pivotal Phase 3 RISE-PD Clinical Trial of IPX-203 in Patients with Parkinsons Disease Who Experience Motor Fluctuations

Amneal Announces Virtual Event to Discuss Initial Data from Pivotal Phase 3 Study of IPX-203 in Patients with Parkinsons Disease Who Experience Motor Fluctuations

Amneal Pharmaceuticals (NYSE:AMRX) investors are sitting on a loss of 77% if they invested three years ago

Amneal Pharmaceuticals, inc (AMRX) Q2 2021 Earnings Call Transcript

Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates

Top Streaming News